Education
About Us
Working with TipRanks
Follow Us
Robert Hariri Insider Profile
4 Followers
Robert Hariri, Director at MedAvail Holdings, holds 51.27K shares in CryoPort (Ticker: CYRX), holds 20.33K shares in Celularity (Ticker: CELU), holds 42.25K shares in BioVie (Ticker: BIVI).
Profitable Transactions
9 out of 23 Profitable Transactions
Average Return
-15.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert Hariri holds in companies
Most Profitable Insider Trade
The most profitable trade made by Robert Hariri
Robert Hariri's Trading History
MedAvail Holdings
Apr 06, 2020
Director
Uninformative Buy
―
―
CryoPort
Sep 12, 2025
Director
Uninformative Buy
66.50K
$503.01K
Celularity
Apr 15, 2025
CEO, Director
Uninformative Buy
3.49K
$44.32K
BioVie
Dec 06, 2023
Director
Uninformative Buy
―
$77.75K
WaferGen Bio systems
Sep 20, 2011
―
Uninformative Buy
―
$1.10M
List of latest transactions for each holding click on a transaction to see Robert Hariri's performance on stock
You May Also Like
Robert Hariri insider profile FAQ
What is the percentage of profitable transactions made by Robert Hariri?
The percentage of profitable transactions made by Robert Hariri is 39%.
What is the average return per transaction made by Robert Hariri?
The average return per transaction made by Robert Hariri is -15.50%.
What stocks does Robert Hariri hold?
Robert Hariri holds: MDVLQ, CYRX, CELU, BIVI, WGBS stocks.
What was Robert Hariri’s latest transaction?
Robert Hariri latest transaction was an Uninformative Buy of $66.50K.
What was Robert Hariri's most profitable transaction?
Robert Hariri’s most profitable transaction was an Informative Buy of CYRX stock on July 31, 2020. The return on the trade was 86.20%.
What is Robert Hariri's role in MedAvail Holdings?
Robert Hariri's role in MedAvail Holdings is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.